DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. $(INO)$ shed 3.03% to $1.28 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.65% to 26,081.72 and Dow Jones Industrial Average falling 0.60% to 52,064.10.

This was the stock's third consecutive day of losses.

Inovio Pharmaceuticals Inc. closed 54.61% short of its 52-week high of $2.82, which the company achieved on September 11th.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.27% to $266.35, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 0.47% to $27.65.

Trading volume (1.9 M) remained 2.1 million below its 50-day average volume of 4.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2026.